Download PDF
Thromb Haemost 1970; 24(01/02): 076-084
DOI: 10.1055/s-0038-1654213
Originalarbeiten – Original Articles – Travaux Originaux
Schattauer GmbH

Some Properties of an Antiplasmin Substance from Rabbit Platelets

K Wakabayashi
1   Tokyo University School of Medicine, Tokyo; First Department of Surgery and First Department of Medicine, Institute for Protein Research, Osaka University, Osaka
,
K Fujikawa
1   Tokyo University School of Medicine, Tokyo; First Department of Surgery and First Department of Medicine, Institute for Protein Research, Osaka University, Osaka
,
T Abe
1   Tokyo University School of Medicine, Tokyo; First Department of Surgery and First Department of Medicine, Institute for Protein Research, Osaka University, Osaka
› Author Affiliations
Further Information

Publication History

Publication Date:
28 June 2018 (online)

Also available at
    Permissions and Reprints

Summary

Rabbit platelets contained a proteinase inhibitor which inhibited plasmin, trypsin and chymotrypsin activities, and serum kallikrein to some extent. It did not inhibit pancreatic kallikrein and thrombin. It reacted stoechiometrically with these enzymes in a prompt fashion and was found to have a molecular weight of about 40,000.

 

  • References

  • 1 Johnson S. A, Schneider G. L. The existence of antifibrinolysin activity in platelets. Science 117: 229 1953;
    CrossrefPubMedSearch in Google Scholar
  • 2 Stefanini M, Murphy I. S. Studies on platelets. XIV. Human platelets as source of antifibrinolysin. J. clin. Invest 35: 355 1956;
    CrossrefPubMedSearch in Google Scholar
  • 3 Sherry S, Alkjaersig N. Studies on the fibrinolytic enzyme of human plasma. Thrombos. Diathes. haemorrh. (Stuttg.) 01: 264 1957;
    PubMedSearch in Google Scholar
  • 4 Holemans R, Gross R. Influence of blood platelets on fibrinolysis. Thrombos. Diathes. haemorrh. (Stuttg.) 06: 196 1961;
    PubMedSearch in Google Scholar
  • 5 Osuga T, Wakabayshi K, Matsuda M, Kazama M, Abe T. Inhibitory effect of blood platelet on plasma fibrinolytic activity. Jap. J. clin. Hematol 09: 504 1968;
    PubMedSearch in Google Scholar
  • 6 Nagasawa S, Suzuki T. A simple method for purification of bovine plasminogen. J. Biochem. (Tokyo) 66: 273 1969;
    CrossrefPubMedSearch in Google Scholar
  • 7 Yano M, Nagasawa S, Suzuki T. Purification and properties of bovine serum kallikrein activated with casein. J. Biochem. (Tokyo). in press.
    PubMed
  • 8 Blombäck B, Blombäck M. Purification of human and bovine fibrinogen. Arkiv Kemi 10: 415 1956;
    PubMedSearch in Google Scholar
  • 9 Berg W, Korsan-Bengsten K. Separation of human fibrinogen and plasminogen by means of gel filtration. Thrombos. Diathes. haemorrh. (Stuttg.) 09: 151 1963;
    PubMedSearch in Google Scholar
  • 10 Remmert L. F, Cohen P. P. Partial purification and properties of a proteolytic enzyme of human serum. J. biol. Chem 181: 431 1949;
    PubMedSearch in Google Scholar
  • 11 Ghan N. M, Mertz E. T. Studies on plasminogen. V. Purification of bovine and human plasminogens by Sephadex chromatography. Canad. J. Biochem 44: 475 1966;
    CrossrefPubMedSearch in Google Scholar
  • 12 Roberts P. S. Measurement of the rate of plasmin action on synthetic substrates. J. biol. Chem 232: 285 1958;
    PubMedSearch in Google Scholar
  • 13 Lowry O. H, Rosenbangh N. J, Fan A. L, Randall R. J. Protein measurement with the Folin phenol reagent. J. biol. Chem 193: 265 1951;
    PubMedSearch in Google Scholar
  • 14 Whitacker J. R. Determination of molecular weights of proteins by gel filtration on Sephadex. Anal. Chem 35: 1950 1963;
    CrossrefPubMedSearch in Google Scholar
  • 15 Wu F. G, Laskowski M. Crystalline acid-labile trypsin inhibitor from bovine blood plasma. J. biol. Chem 235: 1680 1960;
    PubMedSearch in Google Scholar
  • 16 Martin G. J. Inhibition of trypsin, chymotrypsin, and plasmin by an inhibitor isolation from sheep serum. J. biol. Chem 237: 2099 1962;
    PubMedSearch in Google Scholar
  • 17 Schönenberger M, Schmidtberger R, Schultz H. E. Über das α2-Makroglobulin. Z. Naturforsch 136: 761 1958;
    PubMedSearch in Google Scholar
  • 18 Haverback B. J, Dyce B, Bundy H. F, Wirtschafter S. K, Edmondson H. A. Protein binding of pancreatic proteolytic enzymes. J. clin. Invest 41: 972 1962;
    CrossrefPubMedSearch in Google Scholar
  • 19 Ganrot P. O. Interaction of plasmin and trypsin with α2-macroglobulin. Acta chim. scand 21: 602 1967;
    CrossrefPubMedSearch in Google Scholar
  • 20 Nagasawa S, Han B. H, Sugihara H, Suzuki T. Studies on α2-macroglobulin in bovine plasma. I. Purification, physical properties, and chemical composition. J. Biochem. (Tokyo). (In press)
    PubMed
  • 21 Nagasawa S, Han B. H, Sugihara H, Suzuki T. Studies on α2-macroglobulin in bovine plasma. II. Interaction of α2-macroglobulin and trypsin. J. Biochem. (Tokyo). (In press)
    PubMed
  • 22 Vogel R, Trautshold I, Werle E. Natürliche Proteinasen-Inhibitoren. Weitzel G, Zöllner N. Thieme; Stuttgart: 1966
    Search in Google Scholar
  • 23 Jürgens J, Pryzbilski R. Antifibrinolytic activity of platelets. Exp. Biol. Med 03: 181 1968;
    PubMedSearch in Google Scholar
  • 24 McDonagh J, Kiesselbach T. H, Wagner R. H. Factor XIII and antiplasmin activity in human platelets. Amer. J. Physiol 216: 508 1969;
    PubMedSearch in Google Scholar
  • 25 Lorand L, Konishi K. Activation of the fibrin stabilizing factor of plasma by thrombin. Arch. Biochem 105: 58 1964;
    CrossrefPubMedSearch in Google Scholar
  • 26 Warburg O, Christian W. Isolierung und Kristallisation des Gärungsferments Enolase. Biochem. Z 310: 384 1942;
    PubMedSearch in Google Scholar